Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Anchored RSK3 Inhibitors, LLC”

5 pharma patents match "Anchored RSK3 Inhibitors, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Anchored RSK3 Inhibitors, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Anchored RSK3 Inhibitors, LLC” · 30,257 patents in full index Clear search

  1. US 11931402

    Compositions for treating heart disease by inhibiting the action of mAKAP-β

    Anchored RSK3 Inhibitors, LLC · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted

  2. US 11229679

    Compositions for treating heart disease by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  3. US 10617737

    Compositions for treating heart disease by inhibiting the action of mAKAP-β

    Anchored RSK3 Inhibitors, LLC · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  4. US 9937228

    Treatment of myocardial infarction by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  5. US 9132174

    Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

    Anchored RSK3 Inhibitors, LLC · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.